| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
993 |
719 |
$335K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,769 |
1,361 |
$137K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,161 |
996 |
$92K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,396 |
1,037 |
$49K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
704 |
569 |
$34K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
527 |
475 |
$27K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
536 |
488 |
$25K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
514 |
396 |
$12K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
258 |
199 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
237 |
148 |
$3K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
28 |
21 |
$2K |
| 99000 |
|
160 |
126 |
$1K |
| 99383 |
|
17 |
16 |
$1K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
18 |
16 |
$686.88 |
| 81025 |
|
134 |
116 |
$653.06 |
| 81003 |
|
269 |
230 |
$563.40 |
| 36415 |
Collection of venous blood by venipuncture |
295 |
231 |
$95.48 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
28 |
16 |
$40.60 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
21 |
13 |
$25.97 |